Description

Supplementary mechanistic data from a comprehensive review of antioxidant-based therapeutic strategies for inflammatory bowel disease, covering compounds that target oxidative stress pathways.

Figure 31

Diagram

Source Paper

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37631065

DOI: 10.3390/ph16081150

Cite This Figure

![Figure 31: Supplementary mechanistic data from a comprehensive review of antioxidant-based therapeutic strategies for inflammatory bowel disease, covering compounds that target oxidative stress pathways.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Supplementary mechanistic data from a comprehensive review of antioxidant-based therapeutic strategies for inflammatory bowel disease, covering compounds that target oxidative stress pathways." />
  <figcaption>Figure 31. Supplementary mechanistic data from a comprehensive review of antioxidant-based therapeutic strategies for inflammatory bowel disease, covering compounds that target oxidative stress pathways.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>

Related Evidence

Curcumin for Ulcerative Colitis (UC)

Grade B · 5 studies

N-Acetyl Cysteine (NAC) for Inflammatory Bowel Disease (IBD) — General

Grade D · 1 studies